five

A Phase III Randomized, Double-Blind,Placebo-Controlled, Multicenter Study of Icatibant for Subcutaneous Injection in Patients With Acute Attacks of Hereditary Angioedema (HAE)

收藏
DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00006838/isLanding
下载链接
链接失效反馈
官方服务:
资源简介:
This study is being conducted to evaluate the efficacy and safety of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
提供机构:
Vivli
创建时间:
2021-04-07
二维码
社区交流群
二维码
科研交流群
商业服务